Dermatology (22 companies · 13 conditions)

Conditions

Atopic Dermatitis 11 Psoriasis 4 Hidradenitis Suppurativa 2 Rare Onychomycosis 2 Pemphigus 2 Rare Acne 1 Alopecia Areata 1 Androgenetic Alopecia 1 Lichen Planus 1 Lymphatic Malformation 1 Rare Prurigo Nodularis 1 Rosacea 1 Vitiligo 1

Companies

Ticker	Company	Therapeutic areas	In Dermatology	Lead stage	Programs
ABSI	Absci Corporation	DermatologyGI/HepatologyWomen's Health	1	Phase 1	7
ACRS	Aclaris Therapeutics	DermatologyRespiratory	5	Phase 2	7
ALDX	Aldeyra Therapeutics, Inc.	DermatologyOncologyOphthalmology Rare	1	NDA Submitted	8
ANAB	ANAPTYSBIO, INC	DermatologyGI/HepatologyImmunologyOncology Rare	1	Approved	6
APGE	Apogee Therapeutics, Inc.	DermatologyRespiratory	2	Phase 2	8
RCUS	Arcus Biosciences, Inc.	DermatologyImmunologyOncology	1	Phase 3	7
ARTV	Artiva Biotherapeutics, Inc.	DermatologyImmunologyOncologyRenal Rare	1	Phase 2	16
CABA	Cabaletta Bio, Inc.	DermatologyImmunologyNeurologyRenal Rare	1	Phase 1	8
CLDX	Celldex Therapeutics, Inc.	DermatologyGI/HepatologyImmunologyRespiratory	2	Phase 3	7
CRVS	Corvus Pharmaceuticals, Inc.	DermatologyOncology	1	Phase 3	4
ENTA	ENANTA PHARMACEUTICALS INC	DermatologyImmunologyInfectious Disease	1	Phase 2	6
EVMN	Evommune, Inc.	DermatologyImmunologyNeurology	2	Phase 2	6
FBRX	Forte Biosciences, Inc.	DermatologyGI/Hepatology	2	Phase 2	3
FBIO	Fortress Biotech, Inc.	DermatologyHematologyMetabolic Rare	1	Approved	14
KYMR	Kymera Therapeutics, Inc.	DermatologyRespiratory	1	Phase 2	5
GLUE	Monte Rosa Therapeutics, Inc.	CardiovascularDermatologyMetabolicOncology Rare	1	Phase 1	8
ORKA	Oruka Therapeutics, Inc.	DermatologyImmunology Rare	4	Phase 2	6
TARA	Protara Therapeutics, Inc.	DermatologyMetabolicOncology Rare	1	Phase 3	3
RVPH	REVIVA PHARMACEUTICALS HOLDINGS, INC.	CardiovascularDermatologyNeurologyRespiratory Rare	1	Phase 3	10
SGMT	Sagimet Biosciences Inc.	DermatologyMetabolic	3	Phase 3	5
TTRX	Turn Therapeutics Inc.	DermatologyInfectious Disease	3	Phase 2	4
VNDA	Vanda Pharmaceuticals Inc.	CardiovascularDermatologyGI/HepatologyHematologyImmunologyInfectious DiseaseNeurologyOphthalmology Rare	4	Approved	26